Delayed
Japan Exchange
02:00:00 2024-05-02 am EDT
|
5-day change
|
1st Jan Change
|
3,295
JPY
|
+1.23%
|
|
+4.94%
|
+35.54%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
13,578
|
13,675
|
16,001
|
13,732
|
15,788
|
19,765
|
-
|
-
|
Enterprise Value (EV)
1 |
8,741
|
9,181
|
11,632
|
9,702
|
10,022
|
18,296
|
19,765
|
19,765
|
P/E ratio
|
16.2
x
|
16.1
x
|
20.5
x
|
14.4
x
|
26.9
x
|
32
x
|
26
x
|
21.6
x
|
Yield
|
3.37%
|
3.34%
|
2.86%
|
3.75%
|
3.04%
|
3.31%
|
3.64%
|
3.64%
|
Capitalization / Revenue
|
1.31
x
|
1.05
x
|
0.96
x
|
0.73
x
|
0.97
x
|
1.6
x
|
1.37
x
|
1.3
x
|
EV / Revenue
|
1.31
x
|
1.05
x
|
0.96
x
|
0.73
x
|
0.97
x
|
1.6
x
|
1.37
x
|
1.3
x
|
EV / EBITDA
|
12.5
x
|
11.9
x
|
15.2
x
|
10.4
x
|
24.2
x
|
32.9
x
|
22
x
|
18
x
|
EV / FCF
|
15.3
x
|
139
x
|
49.5
x
|
159
x
|
-
|
-238
x
|
36.3
x
|
27.2
x
|
FCF Yield
|
6.53%
|
0.72%
|
2.02%
|
0.63%
|
-
|
-0.42%
|
2.75%
|
3.67%
|
Price to Book
|
1.36
x
|
1.3
x
|
1.24
x
|
0.99
x
|
1.13
x
|
1.21
x
|
1.38
x
|
1.36
x
|
Nbr of stocks (in thousands)
|
5,715
|
5,715
|
5,715
|
5,715
|
5,999
|
5,999
|
-
|
-
|
Reference price
2 |
2,376
|
2,393
|
2,800
|
2,403
|
2,632
|
3,295
|
3,295
|
3,295
|
Announcement Date
|
4/23/19
|
4/23/20
|
4/23/21
|
4/25/22
|
4/25/23
|
4/24/24
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
10,380
|
12,969
|
16,622
|
18,714
|
16,254
|
11,419
|
14,400
|
15,200
|
EBITDA
1 |
1,090
|
1,152
|
1,055
|
1,319
|
651.3
|
600
|
900
|
1,100
|
EBIT
1 |
1,013
|
1,034
|
955
|
1,201
|
567
|
354
|
800
|
1,000
|
Operating Margin
|
9.76%
|
7.97%
|
5.75%
|
6.42%
|
3.49%
|
3.1%
|
5.56%
|
6.58%
|
Earnings before Tax (EBT)
1 |
1,155
|
1,166
|
1,073
|
1,340
|
764
|
725
|
1,000
|
1,200
|
Net income
1 |
844
|
858
|
790
|
974
|
569
|
548
|
730
|
880
|
Net margin
|
8.13%
|
6.62%
|
4.75%
|
5.2%
|
3.5%
|
4.8%
|
5.07%
|
5.79%
|
EPS
2 |
146.4
|
148.6
|
136.5
|
166.8
|
97.82
|
95.26
|
126.8
|
152.9
|
Free Cash Flow
1 |
886.1
|
98.53
|
323.2
|
86.4
|
-
|
-83
|
544
|
726
|
FCF margin
|
8.54%
|
0.76%
|
1.94%
|
0.46%
|
-
|
-0.62%
|
3.78%
|
4.78%
|
FCF Conversion (EBITDA)
|
81.33%
|
8.55%
|
30.63%
|
6.55%
|
-
|
-
|
60.44%
|
66%
|
FCF Conversion (Net income)
|
104.99%
|
11.48%
|
40.92%
|
8.87%
|
-
|
-
|
74.52%
|
82.5%
|
Dividend per Share
2 |
80.00
|
80.00
|
80.00
|
90.00
|
80.00
|
101.0
|
120.0
|
120.0
|
Announcement Date
|
4/23/19
|
4/23/20
|
4/23/21
|
4/25/22
|
4/25/23
|
4/24/24
|
-
|
-
|
Fiscal Period: March |
2020 S1
|
2021 S1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
2025 Q3
|
2025 Q4
|
---|
Net sales
1 |
5,857
|
7,720
|
4,603
|
9,711
|
4,567
|
4,436
|
5,050
|
4,004
|
9,054
|
4,092
|
3,108
|
2,843
|
3,199
|
6,042
|
2,679
|
2,698
|
3,600
|
3,600
|
3,600
|
3,600
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
499
|
405
|
252
|
518
|
366
|
317
|
282
|
137
|
419
|
95
|
53
|
54
|
99
|
153
|
132
|
69
|
190
|
200
|
200
|
210
|
Operating Margin
|
8.52%
|
5.25%
|
5.47%
|
5.33%
|
8.01%
|
7.15%
|
5.58%
|
3.42%
|
4.63%
|
2.32%
|
1.71%
|
1.9%
|
3.09%
|
2.53%
|
4.93%
|
2.56%
|
5.28%
|
5.56%
|
5.56%
|
5.83%
|
Earnings before Tax (EBT)
1 |
565
|
468
|
256
|
582
|
436
|
322
|
376
|
145
|
521
|
148
|
95
|
154
|
109
|
263
|
217
|
245
|
240
|
250
|
250
|
260
|
Net income
1 |
416
|
346
|
189
|
426
|
323
|
225
|
278
|
102
|
380
|
116
|
73
|
119
|
83
|
202
|
168
|
178
|
180
|
180
|
180
|
190
|
Net margin
|
7.1%
|
4.48%
|
4.11%
|
4.39%
|
7.07%
|
5.07%
|
5.5%
|
2.55%
|
4.2%
|
2.83%
|
2.35%
|
4.19%
|
2.59%
|
3.34%
|
6.27%
|
6.6%
|
5%
|
5%
|
5%
|
5.28%
|
EPS
|
72.10
|
59.91
|
-
|
73.17
|
55.17
|
-
|
47.52
|
-
|
64.93
|
19.94
|
-
|
20.74
|
-
|
35.16
|
29.29
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
40.00
|
40.00
|
-
|
40.00
|
-
|
-
|
-
|
-
|
40.00
|
-
|
-
|
-
|
-
|
40.00
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/23/19
|
10/21/20
|
10/25/21
|
10/25/21
|
1/28/22
|
4/25/22
|
7/25/22
|
10/25/22
|
10/25/22
|
1/27/23
|
4/25/23
|
7/24/23
|
10/24/23
|
10/24/23
|
1/26/24
|
4/24/24
|
-
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
4,837
|
4,494
|
4,369
|
4,030
|
5,766
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
886
|
98.5
|
323
|
86.4
|
-
|
-83
|
544
|
726
|
ROE (net income / shareholders' equity)
|
8%
|
8.3%
|
6.7%
|
7.2%
|
4.1%
|
3.9%
|
5.3%
|
6.4%
|
ROA (Net income/ Total Assets)
|
9.16%
|
9.53%
|
7.43%
|
8.11%
|
4.64%
|
3.38%
|
6.3%
|
7.4%
|
Assets
1 |
9,214
|
9,001
|
10,640
|
12,008
|
12,271
|
16,227
|
11,587
|
11,892
|
Book Value Per Share
2 |
1,750
|
1,834
|
2,259
|
2,417
|
2,334
|
2,510
|
2,390
|
2,423
|
Cash Flow per Share
2 |
160.0
|
169.0
|
154.0
|
187.0
|
112.0
|
104.0
|
144.0
|
170.0
|
Capex
1 |
80.7
|
141
|
31.2
|
85.4
|
-
|
100
|
100
|
100
|
Capex / Sales
|
0.78%
|
1.08%
|
0.19%
|
0.46%
|
-
|
0.75%
|
0.69%
|
0.66%
|
Announcement Date
|
4/23/19
|
4/23/20
|
4/23/21
|
4/25/22
|
4/25/23
|
4/24/24
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| +35.54% | 124M | | +14.32% | 64.32B | | -3.80% | 45.95B | | +13.69% | 39.61B | | +20.84% | 25.74B | | +8.66% | 18.75B | | +0.65% | 17.23B | | -21.03% | 15.86B | | +0.81% | 15.03B | | -13.28% | 13.99B |
Other Specialty Chemicals
|